-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

634.O1.6 634. Myeloproliferative Syndromes: Clinical: Molecular Genetics and Prognosis of MPN

Myeloproliferative Syndromes: Clinical Program: Oral and Poster Abstracts
Type: Oral
Sunday, December 6, 2015: 4:30 PM-6:00 PM
W331, Level 3 (Orange County Convention Center)
Moderators:
Vikas Gupta, MD, FRCP, FRCPath, University Health Network and Domenica Caramazza, MD, PhD, Ospedale di Circolo, Fondazione Macchi

Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Mohamad Jawhar1*, Juliana Schwaab, MD1*, Susanne Schnittger, PhD2, Manja Meggendorfer, PhD2*, Karl Sotlar, MD3*, Hans-Peter Horny, MD4*, Georgia Metzgeroth, MD5*, Sebastian Kluger1*, Nicole Naumann1*, Claudia Haferlach, MD2, Torsten Haferlach2, Peter Valent, MD6, Wolf-Karsten Hofmann, MD5, Alice Charlotte Fabarius, PhD5*, Nicholas C.P. Cross, PhD7 and Andreas Reiter, MD8*

1Department of Hematology and Oncology, University Medical Centre Mannheim, Germany, Mannheim, Germany
2MLL Munich Leukemia Laboratory, Munich, Germany
3Ludwig-Maximilians-University Munich, Munich, Germany
4Pathology institute, Ludwig Maximillian’s University, Munich, Germany
5Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany
6Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
7Wessex Regional Genetics Laboratory, University of Southampton, Salisbury, United Kingdom
8Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany

4:45 PM

Ayalew Tefferi, MD1, Terra L. Lasho, PhD2*, Christy Finke, BS3*, Yoseph Elala, MD4*, Daniela Barraco, MD5*, Naseema Gangat, MBBS2, Curtis A. Hanson, MD6, Rhett P. Ketterling, MD7* and Animesh Pardanani, MBBS, PhD8

1Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester
5Mayo Clinic, Rochester, MN
6Division of Hematopathology, Mayo Clinic, Rochester, MN
7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
8Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

5:00 PM

Paola Guglielmelli, MD, PhD1,2*, Giada Rotunno1,2*, Annalisa Pacilli, PhD1,2*, Elisa Rumi, MD3*, Vittorio Rosti, MD4, Federica Delaini, MD5*, Margherita Maffioli, MD6*, Tiziana Fanelli, MSc2*, Alessandro Pancrazzi, BS1,2*, Lisa Pieri, MD, PhD1,7*, Raimonda Fjerza, MD1,2*, Daniela Pietra, PhD3*, Daniela Cilloni, MD8, Francesco Passamonti9*, Alessandro Rambaldi, MD10, Giovanni Barosi, MD4, Tiziano Barbui, MD11*, Mario Cazzola, MD12 and Alessandro M. Vannucchi, MD1,13

1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy
3Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
4Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
5Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
6Division of Hematology, Ospedale di Circolo - Fondazione Macchi Università degli Studi dell'Insubria, Varese, Italy
7Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy
8Dept Hematology and Clinical and Biological Sciences, University of Turin, S Luigi Hospital, Turin, Italy
9Ospedale di Circolo e Fondazione Macchi, Varese, Italy
10Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
11Hospital Papa Giovanni XXIII and Research Foundation, Bergamo, Italy
12Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
13University of Florence, Florence, Italy

5:15 PM

Nicolaus Kroeger, M.D.1, Victoria Panagiota, M.D.2*, Tatjana Zabelina, M.D.1*, Michelle Maria Araujo Cruz, M.D.2*, Rabia Shahswar, M.D.2*, Anita Badbaran1*, Ioanna N Triviai, PhD1*, Francis Ayuk, M.D.3*, Marten Gehlhaar, M.D.2*, Christine Wolschke, M.D.1*, Robin Bollin, M.D.2*, Ulrich Lehmann, M.D.4*, Christian Koenecke, M.D.2*, Anuhar Chaturvedi, PhD, MS, BPharm2*, Haefaa Alchalby, M.D.1*, Michael Stadler, MD2*, Matthias Eder, M.D.2*, Maximilian Christopeit, M.D.1*, Gudrun Göhring, M.D.5*, Michael Koenigsmann, M.D.6, Brigitte Schlegelberger, MD, Prof.5, Hans Heinrich Kreipe, M.D.4*, Arnold Ganser, M.D.7, Boris Fehse, PhD1*, Felicitas Thol, MD7 and Michael Heuser, M.D.2

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
3University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4Institute of Pathology, Hannover Medical School, Hannover, Germany
5Institute of Human Genetics, Hannover Medical School, Hannover, Germany
6Outpatient Oncology Center, Hannover Medical School, Hannover, Germany
7Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

5:30 PM

Paola Guglielmelli, MD, PhD1,2*, Annalisa Pacilli, PhD1,2*, Giada Rotunno, MSc1,2*, Francesca Gesullo, BS1,2*, Alessandro Pancrazzi, BS1,2*, Lisa Pieri, MD, PhD1,2*, Emanuela Sant'Antonio, MD2*, Carmela Mannarelli, MSc2*, Giuseppe Loscocco1,2*, Chiara Paoli, BS1,2*, Lucia Merli, BSN1,2* and Alessandro M. Vannucchi1,2

1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy

5:45 PM

Ayalew Tefferi, MD1, Terra L. Lasho, PhD1*, Christy Finke, BS2*, Yoseph Elala, MD3*, Daniela Barraco, MD4*, Curtis A. Hanson, MD5, Rhett P. Ketterling, MD6*, Animesh Pardanani, MBBS, PhD7 and Naseema Gangat, MBBS1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Hematology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester
4Mayo Clinic, Rochester, MN
5Division of Hematopathology, Mayo Clinic, Rochester, MN
6Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
7Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN

*signifies non-member of ASH